This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Z.
Right arrow Articles by Kawada, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Z.
Right arrow Articles by Kawada, Y.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 1998, p. 3293-3295, Vol. 42, No. 12
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Alteration in the GyrA Subunit of DNA Gyrase and the ParC Subunit of DNA Topoisomerase IV in Quinolone-Resistant Clinical Isolates of Staphylococcus epidermidis

Zhiyu Li, Takashi Deguchi,* Mitsuru Yasuda, Takeshi Kawamura, Emiko Kanematsu, Yoshinori Nishino, Satoshi Ishihara, and Yukimichi Kawada

Department of Urology, Gifu University School of Medicine, Gifu, Japan

Received 18 June 1998/Returned for modification 13 August 1998/Accepted 9 September 1998

We examined 22 clinical isolates of Staphylococcus epidermidis to analyze the association of alterations in GyrA and ParC with fluoroquinolone resistance. The simultaneous presence of GyrA and ParC alterations was associated with a high level of fluoroquinolone resistance in the clinical isolates of S. epidermidis.


* Corresponding author. Mailing address: Department of Urology, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu City, Gifu 500-8705, Japan. Phone: 81-58-265-1241. Fax: 81-58-265-9009. E-mail: deguchit{at}cc.gifu-u.ac.jp.


Antimicrobial Agents and Chemotherapy, December 1998, p. 3293-3295, Vol. 42, No. 12
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Yamada, M, Yoshida, J, Hatou, S, Yoshida, T, Minagawa, Y (2008). Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones. Br J Ophthalmol 92: 848-851 [Abstract] [Full Text]  
  • Escudero, J. A., San Millan, A., Catalan, A., de la Campa, A. G., Rivero, E., Lopez, G., Dominguez, L., Moreno, M. A., Gonzalez-Zorn, B. (2007). First Characterization of Fluoroquinolone Resistance in Streptococcus suis. Antimicrob. Agents Chemother. 51: 777-782 [Abstract] [Full Text]  
  • Oh, H., El Amin, N., Davies, T., Appelbaum, P. C., Edlund, C. (2001). gyrA Mutations Associated with Quinolone Resistance in Bacteroides fragilis Group Strains. Antimicrob. Agents Chemother. 45: 1977-1981 [Abstract] [Full Text]  
  • Linde, H.-J., Schmidt, M., Fuchs, E., Reischl, U., Niller, H.-H., Lehn, N. (2001). In Vitro Activities of Six Quinolones and Mechanisms of Resistance in Staphylococcus aureus and Coagulase-Negative Staphylococci. Antimicrob. Agents Chemother. 45: 1553-1557 [Abstract] [Full Text]  
  • Okhravi, N., Adamson, P., Carroll, N., Dunlop, A., Matheson, M. M., Towler, H. M. A., Lightman, S. (2000). PCR-Based Evidence of Bacterial Involvement in Eyes with Suspected Intraocular Infection. IOVS 41: 3474-3479 [Abstract] [Full Text]  
  • Dong, J., Walker, J., Nitiss, J. L. (2000). A Mutation in Yeast Topoisomerase II That Confers Hypersensitivity to Multiple Classes of Topoisomerase II Poisons. J. Biol. Chem. 275: 7980-7987 [Abstract] [Full Text]  
  • Dubin, D. T., Fitzgibbon, J. E., Nahvi, M. D., John, J. F. (1999). Topoisomerase Sequences of Coagulase-Negative Staphylococcal Isolates Resistant to Ciprofloxacin or Trovafloxacin. Antimicrob. Agents Chemother. 43: 1631-1637 [Abstract] [Full Text]